Entity
Company
Location
55 Cambridge Parkway, Suite 800 E, Cambridge, MA
Signature
Flagship Ventures Fund IV General Partner LLC, By: /s/ Noubar B. Afeyan, Ph.D., Name: Noubar B. Afeyan, Ph.D., Title: Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Flagship Ventures Fund IV General Partner LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Axcella Health Inc. 10%+ Owner Common Stock 14.1M $8.18M $0.58 Oct 13, 2022 By Flagship Ventures Fund IV, L.P.
Axcella Health Inc. 10%+ Owner Common Stock 6.3M $3.65M $0.58 Oct 13, 2022 By Flagship Ventures Opportunities I, L.P.
Axcella Health Inc. 10%+ Owner Common Stock 3.05M $1.77M $0.58 Oct 13, 2022 By FPA, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 3.93M $1.3M $0.33 Jul 11, 2023 By Flagship Pioneering Fund VII, L.P.
Axcella Health Inc. 10%+ Owner Common Stock 2.04M $1.18M $0.58 Oct 13, 2022 By Flagship VentureLabs IV, LLC
Axcella Health Inc. 10%+ Owner Common Stock 2M $1.16M $0.58 Oct 13, 2022 By Flagship Ventures Fund IV-Rx, L.P.
Axcella Health Inc. 10%+ Owner Common Stock 1.76M $1.02M $0.58 Oct 13, 2022 By Flagship Ventures Fund 2007, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 1.49M $493K $0.33 Jul 11, 2023 By Nutritional Health LTP Fund, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 1.46M $482K $0.33 Jul 11, 2023 By Flagship Ventures Fund IV, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 275K $90.7K $0.33 Jul 11, 2023 By Flagship Ventures Opportunities Fund I, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 210K $69.3K $0.33 Jul 11, 2023 By Flagship Ventures Fund V, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 180K $59.4K $0.33 Jul 11, 2023 By Nutritional Health Disruptive Innovation Fund, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 132K $43.7K $0.33 Jul 11, 2023 By Flagship VentureLabs V LLC
Evelo Biosciences, Inc. 10%+ Owner Common Stock 94.4K $31.1K $0.33 Jul 11, 2023 By Flagship Ventures Fund IV-Rx, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 80.5K $26.6K $0.33 Jul 11, 2023 By Flagship V VentureLabs Rx Fund, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 39.8K $13.1K $0.33 Jul 11, 2023 By Nutritional Health Side Fund, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 34.2K $11.3K $0.33 Jul 11, 2023 By Flagship VentureLabs IV LLC

Insider Reports Filed by Flagship Ventures Fund IV General Partner LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EVLO Evelo Biosciences, Inc. Jul 11, 2023 3 $12.5M 4 Jul 13, 2023 10%+ Owner
AXLA Axcella Health Inc. Oct 13, 2022 5 $17M 4 Oct 17, 2022 10%+ Owner
EVLO Evelo Biosciences, Inc. May 27, 2022 5 $40M 4 Jun 1, 2022 10%+ Owner
AXLA Axcella Health Inc. Mar 16, 2022 3 $12.1M 4 Mar 18, 2022 10%+ Owner